Olema Pharmaceuticals Financials
| OLMA Stock | USD 8.91 0.13 1.48% |
Olema |
Understanding current and past Olema Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Olema Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Olema Pharmaceuticals' assets may result in an increase in income on the income statement.
Please note, the presentation of Olema Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Olema Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Olema Pharmaceuticals' management manipulating its earnings.
Olema Pharmaceuticals Stock Summary
Olema Pharmaceuticals competes with Sana Biotechnology, Cullinan Oncology, Zentalis Pharmaceuticals, Molecular Partners, and Mineralys Therapeutics,. Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for womens cancers. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Olema Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US68062P1066 |
| CUSIP | 68062P106 |
| Location | California; U.S.A |
| Business Address | 780 Brannan Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | olema.com |
| Phone | 415 651 3316 |
| Currency | USD - US Dollar |
Olema Pharmaceuticals Key Financial Ratios
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.32 | ||||
| Target Price | 27.86 | ||||
| Number Of Employees | 74 | ||||
| Beta | 2.03 |
Olema Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Olema Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Olema Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Olema Pharmaceuticals competition to find correlations between indicators driving Olema Pharmaceuticals's intrinsic value. More Info.Olema Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Olema Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Olema Pharmaceuticals Systematic Risk
Olema Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Olema Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Olema Pharmaceuticals correlated with the market. If Beta is less than 0 Olema Pharmaceuticals generally moves in the opposite direction as compared to the market. If Olema Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Olema Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Olema Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Olema Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
About Olema Pharmaceuticals Financials
What exactly are Olema Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Olema Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Olema Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Olema Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Olema Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Olema Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Olema Pharmaceuticals November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Olema Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Olema Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Olema Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Olema Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Olema Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 19.19 | |||
| Value At Risk | (5.89) | |||
| Potential Upside | 5.58 |
Complementary Tools for Olema Stock analysis
When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |